140 studies found for:    Open Studies | "Colonic Diseases, Functional"
Show Display Options
Rank Status Study
21 Recruiting A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
Condition: Constipation Predominant Irritable Bowel Syndrome
Interventions: Drug: Tenapanor;   Drug: Placebo
22 Recruiting Mindfulness-based Eating in Patients With Irritable Bowel Syndrome
Conditions: Abdominal Pain;   Irritable Bowel Syndrome;   IBS
Interventions: Dietary Supplement: Dietary intervention;   Behavioral: Irritable Bowel Syndrome eating awareness training
23 Recruiting Retrospective Study of IBS-D Patients Previously Receiving SBI
Condition: Diarrhoea Predominant Irritable Bowel Syndrome
Intervention: Other: EnteraGam
24 Recruiting Gut Microbiota Reconstruction for the Treatment of Diarrhea-predominant Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome
Interventions: Drug: placebo;   Drug: Rifaximin;   Procedure: infusing saline through enteral nutrition tube;   Procedure: FMT with donor stool through enteral nutrition tube
25 Recruiting Confocal Endomicroscopy Utility (p-CLE) in Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome (IBS)
Intervention: Device: Confocal Laser Endomicroscopy
26 Not yet recruiting Afferent Stimulation to Evoke Recto-colonic Reflex for Colonic Motility
Condition: Neurogenic Bowel Dysfunction
Intervention: Other: Electrical Rectal Stimulation
27 Not yet recruiting Colonoscopy-related Pain Predicts the Treatment Response of Amitriptyline in Patients With Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome
Intervention: Drug: Amitriptyline
28 Recruiting A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-C
Condition: Constipation Predominant Irritable Bowel Syndrome
Interventions: Drug: Tenapanor;   Drug: Placebo
29 Recruiting Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome
Condition: Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome
Interventions: Drug: Clostridium Butyricum;   Drug: placebo
30 Not yet recruiting Fructose Breath-testing in Irritable Bowel Syndrome (IBS)
Conditions: Functional Gastrointestinal Disorders;   Irritable Bowel Syndrome
Interventions: Procedure: Open breath test with fructose;   Procedure: Breath test with sweet placebo (Assugrin);   Procedure: Breath test with neutral placebo (still water);   Procedure: Blinded breath test with fructose
31 Recruiting Hypnotherapy vs. Probiotics in Children With IBS and Functional Abdominal Pain
Conditions: Irritable Bowel Syndrome;   Functional Abdominal Pain Syndrome
Interventions: Behavioral: Gut-Directed Hypnotherapy;   Dietary Supplement: Nutritional Supplement;   Behavioral: Self-Monitoring
32 Recruiting Special Drug Use Surveillance of Irribow in Female Patients
Condition: Diarrhea-predominant Irritable Bowel Syndrome
Intervention: Drug: Ramosetron
33 Recruiting SBI in Children With d-IBS
Condition: Irritable Bowel Syndrome
Interventions: Other: Medical Food;   Other: Placebo
34 Recruiting An Open-Label, Long-term Study to Assess the Immunogenicity of Linaclotide Administered Orally to Adult Patients With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation
Conditions: Irritable Bowel Syndrome With Constipation;   Chronic Idiopathic Constipation
Interventions: Drug: Linaclotide 290 micrograms;   Drug: Linaclotide 145 micrograms;   Drug: Linaclotide 72 micrograms
35 Recruiting Pain Relief In Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome
Intervention: Drug: Proklama
36 Recruiting Microbiota Community of Irritable Bowel Syndrome in Episodes and Remission Phase
Condition: Irritable Bowel Syndrome
Intervention: Other: collect faeces from participants
37 Not yet recruiting Efficacy of Rifaximin to Treat Diarrhea-predominant Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome
Intervention:
38 Recruiting Is Microbiota Community Associated With Clinical Response to a Low FODMAP Diet in Patients With Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome
Intervention: Dietary Supplement: low FODMAPs
39 Recruiting A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Condition: Irritable Bowel Syndrome With Constipation
Interventions: Drug: Linaclotide Dose A;   Drug: Linaclotide Dose B;   Drug: Linaclotide Dose C;   Drug: Linaclotide Approved Adult Dose;   Drug: Matching Placebo
40 Recruiting Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Condition: Irritable Bowel Syndrome With Constipation
Interventions: Drug: Linaclotide;   Drug: Matching Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years